Michael J Rossi is PRESIDENT & CEO of Y-mAbs Therapeutics, Inc.. Currently has a direct ownership of 0 shares of YMAB, which is worth approximately $0. The most recent transaction as insider was on Sep 16, 2025, when has been sold 129,101 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Michael J Rossi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 16 2025
SELL
Sale (or disposition) back to the issuer
-
129,101 Reduced 100.0%
0 Common Stock
Sep 16 2025
SELL
Disposition due to a tender of shares in a change of control transaction
$68,645 $8.6 p/Share
7,982 Reduced 100.0%
0 Common Stock
Mar 07 2025
SELL
Open market or private sale
$20,368 $5.2 p/Share
3,917 Reduced 2.78%
137,083 Common Stock
Jan 17 2025
BUY
Grant, award, or other acquisition
-
105,300 Added 42.75%
141,000 Common Stock
Feb 12 2024
BUY
Grant, award, or other acquisition
-
35,700 Added 50.0%
35,700 Common Stock

Also insider at

MIR
Mirion Technologies, Inc. Industrials
MJR

Michael J Rossi

PRESIDENT & CEO
Atlanta, GA

Track Institutional and Insider Activities on YMAB

Follow Y-mAbs Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells YMAB shares.

Notify only if

Insider Trading

Get notified when an Y M Abs Therapeutics, Inc. insider buys or sells YMAB shares.

Notify only if

News

Receive news related to Y-mAbs Therapeutics, Inc.

Track Activities on YMAB